In vivo MRI results demonstrate that mesenchymal stem cells migrate toward a quinolinic acid lesion and can survive for 19 days post-transplantation, which gives hope for future research harnessing stem cells for treating neurodegenerative diseases, such as Huntington's, Alzheimer's and Parkinson's, according to research in this months issue of Stem Cells.